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Lipopolysaechmide (LPS) is a pathogenic substance causing severe multiple organ fadure~ and high mortahty. Although ~eveml LP$ binding 
proteins have been identified, the molecular mechanism underlym/~ the LPS signahn8 pathway stdl remains obscure. We have found that the 
LPS.mduced Ca `-+ increase in platelets and platelet aggregation i  blocked by selective platelet-actwating factor (PAF) r~ptor  antagonists, thus 
suggesting a cross-talk between LPS and the PAF receptor Next, we confirmed this hypothesis ttsmg the cloned PAF receptors [0991) Nature 
349, 342-346; (1991) J. Biol. Chem. 266, 20400--20405] expressed in .Venopu~ oocytes and Chinese hamster ovary (CHO) cells. In both systems, 
cells responded to LPS only when PAF receptors were expressed, and specific PAF binding wa~ successfully displaced and reversibly d~ssociated 
by LPS. PAF receptor act~vatmn by LPS may represent a novel important pathway in the pathogenesis of circulatory collapse and systemic 
thrombos~s caused by endotoxin. 
Platelet-activating factor receptor, Endotoxm, Lipid A; Calcmm signaling; Platelet 
I. INTRODUCTION 
Lipopolysaccharidc (LPS), a major lipid constituent 
of the outer membrane of Gram-negative bacteria, is a 
potent pathological agent which causes circulatory col- 
lapse, systemic thrombosis, multiple organ failures and 
high mortality [1,2]. Several lines of evidence indicate 
that an LPS-LPS binding protein (LBP) complex bind 
to the cell surface CDI4 molecule [3,4]. It was also 
reported that the macrophage scavenger eceptor binds 
and degrades endotoxic lipids [S]. However, little is 
known of the functional receptor of LPS and its signal- 
ing pathway. Several investigators reported that PAF 
atttagonists, such as WEB 2086, CV-3988, BN 50739, 
and SRI 63-675, are likely to have considerable utility 
as specific agents for treating eases of' endotoxemic 
shock or disseminated intravascular coagulation [6]. Al- 
though there may exist a specific LPS receptor in certain 
cells [7,8], we propose here that a part of the pathologi- 
cal actions of LPS, such as platelet aggregation [9-12], 
are due to direct activation of the PAF receptor by LPS. 
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2. MATERIALS AND METHODS 
2.1. Matertals 
[~HIPAF (4 23 TBq/mmol) was obtained from Amersham (Tokyo, 
Japan). The PAF antagomst, Y-24180. was donated from Yoshltoml 
Pharmaceutical Industries Ltd. (Osaka). WEB 2086 was from 
Boehringer-lngelheim (lngelheim, Germany) Other materials and re- 
agents were of analytical grade. 
2.9. Preparattou of rabbet platetet.s 
Rabbit blood v.as mixed with a 1/9 eel of 3.8% (w/v) trisodiam 
curate and centrifuged at 300 × g for 15 rain to obtain platelet-rich 
plasma. Platelets wer~ isolated by centrifugation at 1,500 x g for 15 
mm and suspended in HEPES/Tyrode buffer (140 mM NaCI, 2 7 mM 
KCI° 12 mM NaHCO3, 0.49 mM MgCI~, 0,37 mM NaH:PO.~, 56 mM 
glucose, 25 mM HEPES, pH 7,4). 
2.3. Mea3uretnent of platdet aggregatton 
Platelet aggregauon was measured at 370C with stirring according 
to the method of Born [:3] and monitored in a CAF-100 spec- 
trofluorometer (Japan Spectroscopy Inc.). Antagoniats were added 5 
rain before the measurement 
2.4. Measurement of ntraeelhdar calcium concentration 
The cells were incubated in HEPES/Tyrode buffer containing 3,aM 
Fura-2-pentaacetoxymethyi ster (Dojin) for i.5 h at room tempera- 
ture. The Fura-2-1oaded cells were washed with and resuspended in 
HEPES/'l'yrode butter (10 B celis/ml), and the fluorescence of the cells 
was measured with a CAF-100 speetroflucrometer (Japan Spectros- 
copy lnc ) w~th excitation at 340 nm and 380 am, and emission at 500 
nm at 37°C. 1 raM or CaCI2 and test substances were added with 
micro~yrin/~es. Antagonists were pro-incubated for 5 rain. The free 
Ca:" concentration was calculated from the equation 
[Ca:']. = KdlfF-F~,,,)/(rm,,-,~ ] 
where Ka repre~ent~ he Ca ~-÷ binding di.~ociatmn constant (224 nM 
for Fura-2), F ts the 560 nlJl tie, credence ratio, F~,~ is the maximal 
Pt~blislled by Elsevier Science Rubltsher.Y B. V 125 
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fluorescence ratio determined after uddiuon of 0 1% Triton X-100 to 
permeabdize the eelh in the presence of 1 mM Ca -'~, and F,,,~ is the 
minimal fluorescence ratio d=termined alter the addition of 5 mM 
EGTA. 
2,5 Expression of  PAF Jeceptor hz Xenopu~ oocvte,~ 
Human leukocyte PAF recepto~ cRNA wa~ synthesmed as de- 
scribed [14] and injected into defolliculated oocytes (about 50 ng in 50 
ni per oocyte), which were then incubated at 20°C for 3 days The 
Iigand-induced CI- current was recorded as described [15], 
2.6 Ex'pression of  PAF receptcn" hz CHO-KI celia 
The lull-length guinea-plg ung PAF receptor cDNA was ~ubcloned 
into the mammalian expression vector, pRc/CMV (invitrogen), and 
stably transfccted mCHO-KI celh (CHO[gpPAFR]), These cells were 
grown, at 37"C under 5% CO.. in a humidified atmosphere, in Ham's 
F-12 medium supplemented with 10% fetal bovine ~erum. The cells 
were collected by scraping, and washed once with HEPES/Tyrode 
buffer 
2.7. Bmclmg assay 
Preparation of cell membranes and the binding assay wele pei- 
formed as described [14], 
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3. RESULTS AND DISCUSSION 
It has been reported that lipid A, an active moiety of  
LPS, stimulates human platelets, inducing aggregation 
and intracellular Ca ~'+ increase [ 16,17]. We examined the 
effects of LPS or lipid A on intraceilular C~,, ~-+ mobiliza- 
tion in rabbit platelets. As shown in Fig. la, upon addi- 
tion of LPS (5 × 10 -~ g/ml) or lipid A (2 × 10 -~ M) to 
the rabbit platelets, intracellular Ca-** was elevated, and 
this response was completely inhibited by the PAF an- 
tagonist, Y-24180 [18,19] (10 -6 M), in a similar manner 
as for PAF-elicited responses. Y-24180 at 10 -6 M also 
inhibited the LPS- or lipid A-induced Ca ~'~" response in 
human platelets. Moreover, the effect of PAF antago- 
nist was tested in vitro on aggregation of rabbit plate- 
lets. As shown in Fig. lb, upon addition of PAF (10 -=° 
M) or LPS (5 × 10 -5 g/ml) to platelets, irreversible aggre- 
gation was observed which reached a maximum within 
5 rain and 7 rain, respectively. Y-24180 at 10 -6 M com- 
pletely inhibited either PAF- or LPS-induced platelet 
aggregation. These results raised the possibility that a 
part of the LPS signaling pathway utilizes the signal 
transduetion system of the PAF receptor. We previ- 
ously cloned and characterized the cDNAs for guinea 
pig lung and human leukocyte PAF receptors using the 
gene expression system in Xenopus laevis oocytes 
[14,15]. To obtain direct evidence that LPS activates the 
PAF receptor, we carried out the following experiments 
using the cloned receptors. 
In the Xenopus ooeytes expression system, PAF- 
evoked eleetrophysiological responses were oscillatory 
and long-lasting, thus being characteristic of the re- 
sponse mediated through activation of the inositol trig- 
phosphate/calcium second messenger system [20]. The 
ooeytes injected with guinea pig or human PAF recep- 
tor cRNA showed a prominent electrophysiological re-
sponse to the application of LPS (5 x 10 -s g/ml) or lipid 
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Fig. 1. Effect of PAF antagonists on PAF-, LPS- or lipid A-induced 
calcmm responses in Fura-2 loaded rabb~t platelets. (a) Representative 
tracings of :ntracellular calcium rnobdL~ation by PAF  (10 -" M), LPS 
(5 × 10 --~ g/ml) or hpid A (2 x 10 -~ M)  m rabbit platelets m tb.¢ presence 
O1 dbsence of Y-24180 (10 -° M). (b) Aggregation of platelets (2 x l0 s 
celWml) induced by PAF ( 10-~o M) (left panel) or LPS (5 x 10 -s g/ml) 
(right panel) in the presence or absence of Y-24180 (10-" M). 
A (2 × 10 -c' M) (Fig. 2b), whereas the water-injected 
oocytes elicited no detectable response to these agents 
(n = 75, Fig. 2a). Various PAF antagonists (Y-24180 
and WEB 2086) inhibited LPS- or lipid A-induced re- 
sponses (data not shown). These results were reproduc- 
ible in different lots and sources of  LPSs (E. colt 
0i l i :B4  from Dit'co; E. coli 0127:B8 ~ --- " ' °  tfulh z.*liCO arid 
Sigma). As shown in Fig. 2e, the lipid A-evoked re- 
sponse was readily desensitized, aswas the LPS-induced 
response (data not shown). In addition, oocytes which 
126 
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Fig 2. PAF-, I.PS- and hl~ld A-reduced Cl- currents m Xenopus  oocytes. (a) The electrophysioloBical re~ponse~ to LFS, lipid A and PAF in ooeyt¢~ 
injected with htenle water (b) The responses toLPS, lipid A and PAF in oocy,es injected with the transcript orthe human leukocyte. PAF receptor 
eDNA. (e) Desensitization r the hpid A response, and the response to LPS alter application of PAF in oocyte5 rejected with human leukocyte 
PAF receptor cRINA. The coneentration~ u ed were: LPS 5 × 10 -s #ml; lipid A (Daiiehl Pur~ Chem )2 × 10 -* M, and PAF 10 -~ M. The downward 
deflection i dicates the inward current The bar above the current race shows the duration of drub application 
had shown the nearly maximal response (>1/tA)  after 
application of  PAF showed no detectable response to 
LPS. These results strongly indicate that LPS and lipid 
A both act as agonists for the cloned PAF receptors. 
To further confirm this observation, we examined the 
cellular response to LPS and lipid A through the PAF 
receptor stably transfected into CHO cells 
(CHO[~,pPAFR]). As shown in Fig. 3b, the intracellular 
Ca 2. concentration was increased in Fura-2 loaded 
CHO[gpPAFR]  cells following the application of  either 
LPS or lipid A, in a similar manner as seen after PAF 
application, whereas no response was detectable using 
10 -6 M lyso-PAF (data not shown). The mock-trans- 
t'ected control cells (CHO[Vec]) showed a minimal re- 
sponse to PAF but no detectable response to either LPS 
or lipid A (Fig. 3a). The absence or LPS binding to 
parental cells (CHO-KI )  has already been demon~ 
strated by other investigators [5,21]. These elevations in 
Ca ~ were dose .4 . . . .  A . . . . . . . . . . .  g/ha.! *'"d , , ,~v , . ,  . . . . .  b . . . . . . . .  5 x !O -a _.. 5 
× 10 -5 g/ml for LPS and between 2 × 10 -9 M and 2 × 10 -6 
M for lipid A (Fig. 3c and d). Although the local con- 
centration of  LPS in endotoxemic shock remains unde- 
termined, ECho values for LPS (around 10 -6 g/ml) and 
lipid A (around 10 -7 M) correlated well with data ob- 
served previously by others with human platelets [17] 
and murine peritoneal macrophages [22]. Y-24180, at a 
concentration of  10 -6 M, reduced the PAF (10 -a M)- 
elicited Ca 2+ response by 90%, and completely inhibited 
the LPS (5 x 10 -5 g/ml)- or the lipid A (2 × 10 -~ M)- 
evoked responses (Fig. 3c and d). 
To exclude the possibility that LPS- or lipid A-in- 
duced Ca ~'÷ mobilization is due to a rapid production of  
PAF, we measured PAF  production in LPS- or lipid 
A-stimulated CHO[gpPAFR]  cells. Total lipids were ex- 
tracted and separated by thin layer chromatography 
[23] to collect the PAF-containing fraction. PAF con- 
tents were measured using [t25I]PAF Radioimmunoas- 
say Kits (Du Pont). In this system, no production of  
PAF was observed by either LPS (5 x 10 -~ g/ml) or lipid 
A (2 × 10 -6 M) stimulation within 2 min, whereas the 
LPS-induced responses occurred practically instantane- 
ously (Fig. 3b). 
To obtain direct evidence that LPS binds to the PAF 
receptor molecule, the displacement of[SH]PAF binding 
127 
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by LPS was examined using membranes prepared from 
CHO[gpPAFR] cells. LPS effectively blocked the spe- 
cific binding of [~H]PAF in a dose-dependent mant~er 
(Fig. 4a). The IC~o value was about 5 × 10 -~ g/ml, and 
~0~ of'[~I-JJP,=tF bJ~d~n~ was ~n~zib~zcd by5 x }O -~ ~;m~ 
LP$. This IC~0 va}ue was comparab}e w~th the EC~0 
value that evoked the Ca ~-~ response in CHO[gpPAFR] 
cells (Fig. 3e). As shown in Fig. 4b, when LPS (l × 10 -4 
g/ml) was added to the incubation mixture 30 rain after 
[~H]PAF binding, dissociation of [~H]PAF was ob- 
served with a half-life of 60 min. These data provide 
confirmative evidence that LPS binds directly to the 
PAF receptor. 
Other signals of LPS, however, such as synthesis of 
tumor necrosis factor (TNF)-~x in human monocytes, 
was not inhibited by PAF antagonists (I. Waga et al., 
unpublished data). We propose, therefore, that LPS ex- 
erts a variety of biological effects via several distinct 
pathways. 
We have shown herein the first evidence that at least 
a part of the LPS-signaling pathway, which is involved 
in platelet aggregation, utilizes the signal-transduction 
system mediated by direct activation of the PAF recep- 
tor. The pathophysiological significance of' this cross- 
talk needs to be further examined in other organs in- 
volved in endotoxemic shock. 
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Fig. 4. Displacement (a) and dissociation (b) of [~HJPAF binding to membranes of CitO[gpPAFR] cells by LPS. Each point represents he mean 
of duplicate determinations. ReSLIts are from one of three independent experiments. (a) [q-I]PAF (5 × 10 -t° M) bindingeompetition study was carried 
out as d,'seribed [14] except with an incubation time of 150 mix. Data are expressed as a percentage of the binding wtthout LPS (100%) vs. the 
logarithm of the LPS concentration. (b)[~H]PAF (5 x 10 -t° M) was incubated with CHOLgpPAFR] e¢ll membranes at 25"C. Dissoekation f[~H]PAF 
binding was determined by addition of LPS (10 -~ g/ml) at 30 mix (indicated by an arrow). Data are plotted as radtohgand sp,'clfie binding vs. 
incubation time. 
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